Description
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
Product Unit Size | Cost | Quantity | Stock |
---|
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
Cas No. | 104180-18-9 |
---|---|
Purity | ≥95% |
Formula | C27H43N3O5S |
Formula Wt. | 565.74 |
Synonym | Chemotactic peptide, N-Formyl-Met-Leu-Phe-Lys |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.
Synthetic ITC.
Dihydropyridine; L-type Ca2+ channel blocker.
Pyrimidine nucleoside analog; DNA synthesis inh...
PDK1 and Akt inhibitor.
Isoxazole derivative; HSP90 inhibitor.
EphB4 inhibitor.
Peptide fragment of HER2/neu/erbB2 receptor.
NSAID; CB1 agonist, COX-2 inhibitor.
Cyclosporin metabolite; formyl peptide inhibito...
Antimicrobial peptide found in bee and wasp ven...
Diaminoquinazoline derivative.
Endogenous peptide, involved in vascular contra...
Endogenous peptide hormone inolved in gastric e...
Naturally produced ITC, sulfonyl analog of sulf...
Macrolide; peptidyl transferase inhibitor, prot...
VEGFR inhibitor.
Endogenous peptide, involved in paracrine and a...
Phytochemical from Nigella sativa.
Polypeptide antibiotic produced from Streptomyc...
TGF-β1 inhibitor.